Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (51-60 of 315) with videos related to

Pageof 32
Sort By:
European Journal of Medicinal Chemistry|July 2, 2013
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studiesKamaljit Singh, Hardeep Kaur, Kelly Chibale, et al.
Journal of Medicinal Chemistry|July 23, 2021
Medicinal Chemistry Out of AfricaKelly Chibale, Kathryn J Wicht, John G Woodland
Biochemical Pharmacology|November 22, 2005
Arylpiperazines displaying preferential potency against chloroquine-resistant strains of the malaria parasite Plasmodium falciparumCarrie-Anne Molyneaux, Miriam Krugliak, Hagai Ginsburg, et al.
Journal of Medicinal Chemistry|January 9, 2020
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)Peter Mubanga Cheuka, Godwin Dziwornu, John Okombo, et al.
ACS Infectious Diseases|July 1, 2021
Rv0684/<i>fusA1</i>, an Essential Gene, Is the Target of Fusidic Acid and Its Derivatives in <i>Mycobacterium tuberculosis</i>Vinayak Singh, Godwin Akpeko Dziwornu, Amanda Mabhula, et al.
Rapid Communications in Mass Spectrometry : RCM|September 15, 2012
Comparison of electrospray ionisation, atmospheric pressure chemical ionisation and atmospheric pressure photoionisation for the identification of metabolites from labile artemisinin-based anti-malarial drugs using a QTRAP® mass spectrometerStefan Louw, Mathew Njoroge, Nyaradzo Chigorimbo-Murefu, et al.
Trends in Parasitology|June 29, 2023
Developing kinase inhibitors for malaria: an opportunity or liability?Koketso S P Mogwera, Kelly Chibale, Lauren B Arendse
Current Topics in Medicinal Chemistry|March 16, 2011
The state of the art in anti-malarial drug discovery and developmentJeremy N Burrows, Kelly Chibale, Timothy N C Wells
ACS Medicinal Chemistry Letters|August 18, 2022
Innovation Experiences from Africa-Led Drug Discovery at the Holistic Drug Discovery and Development (H3D) CentreVinayak Singh, Dickson Mambwe, Constance Mawunyo Korkor, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitroChitalu C Musonda, Susan Little, Vanessa Yardley, et al.
Pageof 32

Showing results (51-60 of 315) with videos related to

Sort By:
Pageof 32
European Journal of Medicinal Chemistry|July 2, 2013
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studiesKamaljit Singh, Hardeep Kaur, Kelly Chibale, et al.
Journal of Medicinal Chemistry|July 23, 2021
Medicinal Chemistry Out of AfricaKelly Chibale, Kathryn J Wicht, John G Woodland
Biochemical Pharmacology|November 22, 2005
Arylpiperazines displaying preferential potency against chloroquine-resistant strains of the malaria parasite Plasmodium falciparumCarrie-Anne Molyneaux, Miriam Krugliak, Hagai Ginsburg, et al.
Journal of Medicinal Chemistry|January 9, 2020
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)Peter Mubanga Cheuka, Godwin Dziwornu, John Okombo, et al.
ACS Infectious Diseases|July 1, 2021
Rv0684/<i>fusA1</i>, an Essential Gene, Is the Target of Fusidic Acid and Its Derivatives in <i>Mycobacterium tuberculosis</i>Vinayak Singh, Godwin Akpeko Dziwornu, Amanda Mabhula, et al.
Rapid Communications in Mass Spectrometry : RCM|September 15, 2012
Comparison of electrospray ionisation, atmospheric pressure chemical ionisation and atmospheric pressure photoionisation for the identification of metabolites from labile artemisinin-based anti-malarial drugs using a QTRAP® mass spectrometerStefan Louw, Mathew Njoroge, Nyaradzo Chigorimbo-Murefu, et al.
Trends in Parasitology|June 29, 2023
Developing kinase inhibitors for malaria: an opportunity or liability?Koketso S P Mogwera, Kelly Chibale, Lauren B Arendse
Current Topics in Medicinal Chemistry|March 16, 2011
The state of the art in anti-malarial drug discovery and developmentJeremy N Burrows, Kelly Chibale, Timothy N C Wells
ACS Medicinal Chemistry Letters|August 18, 2022
Innovation Experiences from Africa-Led Drug Discovery at the Holistic Drug Discovery and Development (H3D) CentreVinayak Singh, Dickson Mambwe, Constance Mawunyo Korkor, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitroChitalu C Musonda, Susan Little, Vanessa Yardley, et al.
Pageof 32